60 related articles for article (PubMed ID: 25344677)
1. KCNJ1 inhibits tumor proliferation and metastasis and is a prognostic factor in clear cell renal cell carcinoma.
Guo Z; Liu J; Zhang L; Su B; Xing Y; He Q; Ci W; Li X; Zhou L
Tumour Biol; 2015 Feb; 36(2):1251-9. PubMed ID: 25344677
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of BRAF-activated long non-coding RNA is associated with the proliferation of clear cell renal cell carcinoma.
Xue S; Jiang SQ; Li QW; Wang S; Li J; Yang S; Zhang HM; Xu YF; Wang LS; Zheng JH
BMC Urol; 2018 Sep; 18(1):79. PubMed ID: 30200918
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of nuclear protein 1 in the resistance to axitinib in clear cell renal cell carcinoma].
Liu YC; Wu ZL; Ge LY; DU T; Wu YQ; Song YM; Liu C; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):781-792. PubMed ID: 37807730
[TBL] [Abstract][Full Text] [Related]
4. The role of
Ma Z; Qi Z; Shan Z; Li J; Yang J; Xu Z
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28923830
[TBL] [Abstract][Full Text] [Related]
5. RUNX1 predicts poor prognosis and correlates with tumor progression in clear cell renal carcinoma.
Ma J; He S; Li M; Peng Y; Yang X; Chen L; Jia Q; Liu Y
Pathol Res Pract; 2023 Nov; 251():154886. PubMed ID: 37844486
[TBL] [Abstract][Full Text] [Related]
6. A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma.
Xiao Y; Li S; Zhang M; Liu X; Ju G; Hou J
Evid Based Complement Alternat Med; 2022; 2022():5490644. PubMed ID: 35722147
[TBL] [Abstract][Full Text] [Related]
7. KIF4A Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Proliferation in vitro and in vivo.
Yang GH; Ren ZX; Yang X; Zhang YG
Onco Targets Ther; 2020; 13():2667-2676. PubMed ID: 32280241
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of GDF15 suppresses ferroptosis and predicts unfavorable prognosis in clear cell renal cell carcinoma.
Yang D; He Z; Lu J; Yuan X; Liu H; Xue Y; Chen T; Gu H
Cell Div; 2023 Dec; 18(1):21. PubMed ID: 38082448
[TBL] [Abstract][Full Text] [Related]
9. Expression of Concern: The role of CRP and ATG9B expression in clear cell renal cell carcinoma.
Biosci Rep; 2023 Apr; 43(4):. PubMed ID: 37021729
[No Abstract] [Full Text] [Related]
10. Retraction: The role of CRP and ATG9B expression in clear cell renal cell carcinoma.
Biosci Rep; 2023 Jun; 43(6):. PubMed ID: 37656514
[No Abstract] [Full Text] [Related]
11. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
[TBL] [Abstract][Full Text] [Related]
12. Endoplasmic reticulum stress in breast cancer: a predictive model for prognosis and therapy selection.
Yang B; Wang S; Yang Y; Li X; Yu F; Wang T
Front Immunol; 2024; 15():1332942. PubMed ID: 38440732
[TBL] [Abstract][Full Text] [Related]
13. Genome-Wide Integrative Transcriptional Profiling Identifies Age-Associated Signatures in Dogs.
Kim HS; Jang S; Kim J
Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372311
[TBL] [Abstract][Full Text] [Related]
14. Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis.
Peng L; Cao Z; Wang Q; Fang L; Yan S; Xia D; Wang J; Bi L
Front Oncol; 2022; 12():963483. PubMed ID: 36313709
[TBL] [Abstract][Full Text] [Related]
15. Potassium channel-related genes are a novel prognostic signature for the tumor microenvironment of renal clear cell carcinoma.
Zeng R; Li Y; He DM; Sun MZ; Huang WQ; Wang YH; Zhuo YM; Chen JJ; Chen TH; Guo JH; Huang J
Front Oncol; 2022; 12():1013324. PubMed ID: 36237326
[TBL] [Abstract][Full Text] [Related]
16. Common pathways and functional profiles reveal underlying patterns in Breast, Kidney and Lung cancers.
Romera-Giner S; Andreu Martínez Z; García-García F; Hidalgo MR
Biol Direct; 2021 May; 16(1):9. PubMed ID: 34039407
[TBL] [Abstract][Full Text] [Related]
17. Epigenome-wide scan identifies differentially methylated regions for lung cancer using pre-diagnostic peripheral blood.
Zhao N; Ruan M; Koestler DC; Lu J; Marsit CJ; Kelsey KT; Platz EA; Michaud DS
Epigenetics; 2022 Apr; 17(4):460-472. PubMed ID: 34008478
[TBL] [Abstract][Full Text] [Related]
18. Integrated bioinformatic analysis identifies COL4A3, COL4A4, and KCNJ1 as key biomarkers in Wilms tumor.
Guo C; Jiang X; Guo J; Wu Y; Bao G
Int J Clin Exp Pathol; 2021; 14(2):196-208. PubMed ID: 33564352
[TBL] [Abstract][Full Text] [Related]
19. pH-Channeling in Cancer: How pH-Dependence of Cation Channels Shapes Cancer Pathophysiology.
Pethő Z; Najder K; Carvalho T; McMorrow R; Todesca LM; Rugi M; Bulk E; Chan A; Löwik CWGM; Reshkin SJ; Schwab A
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32887220
[TBL] [Abstract][Full Text] [Related]
20. Combination of the PI3K inhibitor Idelalisib with the conventional cytostatics cytarabine and dexamethasone leads to changes in pathway activation that induce anti-proliferative effects in B lymphoblastic leukaemia cell lines.
Sklarz LM; Gladbach YS; Ernst M; Hamed M; Roolf C; Sender S; Beck J; Schütz E; Fischer S; Struckmann S; Junghanss C; Fuellen G; Murua Escobar H
Cancer Cell Int; 2020; 20():390. PubMed ID: 32817744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
